Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Buisson

Showing results (91-100 of 166) with videos related to

Pageof 17
Sort By:
World Journal of Gastroenterology|June 9, 2016
Endoscopy-based management decreases the risk of postoperative recurrences in Crohn's diseaseAnne-Laure Boucher, Bruno Pereira, Stéphanie Decousus, et al.
Scandinavian Journal of Gastroenterology|June 20, 2022
How are patients' preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn's disease patientsSolène Brunet-Houdard, Fanny Monmousseau, Geoffrey Berthon, et al.
Scandinavian Journal of Gastroenterology|February 21, 2022
Predictors of each quality of life dimension in Crohn's disease patients initiating an anti-TNF treatment: differentiated effects of patient-, disease-, and treatment-related characteristicsFanny Monmousseau, Lucile Mulot, Emmanuel Rusch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's DiseaseErwin Dreesen, Filip Baert, David Laharie, et al.
Medicine|October 15, 2016
Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomesCyril Garrouste, Dany Anglicheau, Nassim Kamar, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-AnalysisBruce E Sands, Laurent Peyrin-Biroulet, Stefan Schreiber, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 3, 2019
Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn's DiseaseNassim Hammoudi, Dominique Cazals-Hatem, Claire Auzolle, et al.
Infection Prevention in Practice|January 5, 2023
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control studyAurelien Amiot, Anne Bourrier, Jean-Marc Gornet, et al.
Gut|February 23, 2019
T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrenceMatthieu Allez, Claire Auzolle, Marjolaine Ngollo, et al.
Journal of Crohn'S & Colitis|September 20, 2022
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysisPauline Rivière, Joel Pekow, Nassim Hammoudi, et al.
Pageof 17

Showing results (91-100 of 166) with videos related to

Sort By:
Pageof 17
World Journal of Gastroenterology|June 9, 2016
Endoscopy-based management decreases the risk of postoperative recurrences in Crohn's diseaseAnne-Laure Boucher, Bruno Pereira, Stéphanie Decousus, et al.
Scandinavian Journal of Gastroenterology|June 20, 2022
How are patients' preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn's disease patientsSolène Brunet-Houdard, Fanny Monmousseau, Geoffrey Berthon, et al.
Scandinavian Journal of Gastroenterology|February 21, 2022
Predictors of each quality of life dimension in Crohn's disease patients initiating an anti-TNF treatment: differentiated effects of patient-, disease-, and treatment-related characteristicsFanny Monmousseau, Lucile Mulot, Emmanuel Rusch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's DiseaseErwin Dreesen, Filip Baert, David Laharie, et al.
Medicine|October 15, 2016
Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomesCyril Garrouste, Dany Anglicheau, Nassim Kamar, et al.
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-AnalysisBruce E Sands, Laurent Peyrin-Biroulet, Stefan Schreiber, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 3, 2019
Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn's DiseaseNassim Hammoudi, Dominique Cazals-Hatem, Claire Auzolle, et al.
Infection Prevention in Practice|January 5, 2023
Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control studyAurelien Amiot, Anne Bourrier, Jean-Marc Gornet, et al.
Gut|February 23, 2019
T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrenceMatthieu Allez, Claire Auzolle, Marjolaine Ngollo, et al.
Journal of Crohn'S & Colitis|September 20, 2022
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysisPauline Rivière, Joel Pekow, Nassim Hammoudi, et al.
Pageof 17